CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
6.37
-0.09 (-1.39%)
At close: Mar 18, 2026, 4:00 PM EDT
6.38
+0.01 (0.15%)
After-hours: Mar 18, 2026, 7:48 PM EDT
CorMedix Employees
CorMedix had 191 employees as of December 31, 2025. The number of employees increased by 126 or 193.85% compared to the previous year.
Employees
191
Change (1Y)
126
Growth (1Y)
193.85%
Revenue / Employee
$1,631,984
Profits / Employee
$848,518
Market Cap
503.55M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 191 | 126 | 193.85% | 191 | 0 |
| Dec 31, 2024 | 65 | -18 | -21.69% | 64 | 1 |
| Dec 31, 2023 | 83 | 42 | 102.44% | 82 | 1 |
| Dec 31, 2022 | 41 | 11 | 36.67% | 40 | 1 |
| Dec 31, 2021 | 30 | -5 | -14.29% | 29 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Lyell Immunopharma | 300 |
| Rocket Pharmaceuticals | 202 |
| ADC Therapeutics | 193 |
| Rigel Pharmaceuticals | 174 |
| Allogene Therapeutics | 152 |
| DBV Technologies | 117 |
| Verastem | 102 |
CRMD News
- 13 days ago - CorMedix Inc. (CRMD) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - CorMedix stock drops after earnings: is this dip a buy before key catalyst? - Invezz
- 13 days ago - CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 16 days ago - CorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026 - GlobeNewsWire
- 4 weeks ago - CorMedix Inc. (CRMD) Analyst/Investor Day Transcript - Seeking Alpha
- 4 weeks ago - CorMedix to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - CorMedix Therapeutics Announces Share Repurchase Program - GlobeNewsWire
- 6 weeks ago - CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026 - GlobeNewsWire